Altogether, these results point out the need for additional HL and GCT specific markers, such as CD30 and GPC3 [54], OCT3/4 [55], PLAP [56], for specific identification and classification of these two tumor subtypes, respectively. Here, TNFRSF8 is linked to neoplasm.